These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14746631)

  • 1. Infliximab therapy for sarcoidosis (lupus pernio).
    Haley H; Cantrell W; Smith K
    Br J Dermatol; 2004 Jan; 150(1):146-9. PubMed ID: 14746631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents.
    Baughman RP; Lower EE
    Am J Clin Dermatol; 2004; 5(6):385-94. PubMed ID: 15663335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short course of infliximab for disfiguring lupus pernio.
    Kiorpelidou D; Gaitanis G; Zioga A; Bassukas ID
    Eur J Dermatol; 2008; 18(6):727-9. PubMed ID: 19049948
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of lupus pernio: results of 116 treatment courses in 54 patients.
    Stagaki E; Mountford WK; Lackland DT; Judson MA
    Chest; 2009 Feb; 135(2):468-476. PubMed ID: 18812454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous sarcoidosis.
    Marchell RM; Judson MA
    Semin Respir Crit Care Med; 2010 Aug; 31(4):442-51. PubMed ID: 20665394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
    Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
    J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for refractory sarcoidosis.
    Baughman RP; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):70-4. PubMed ID: 11354550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for treating sarcoidosis patients, Portuguese experience.
    Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
    Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease.
    Tu J; Chan J
    Australas J Dermatol; 2014 Nov; 55(4):279-81. PubMed ID: 23651297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of sarcoidosis with infliximab.
    Doty JD; Mazur JE; Judson MA
    Chest; 2005 Mar; 127(3):1064-71. PubMed ID: 15764796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.
    Field S; Regan AO; Sheahan K; Collins P
    Clin Exp Dermatol; 2010 Oct; 35(7):795-6. PubMed ID: 20831604
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.
    Baughman RP; Judson MA; Teirstein A; Lower EE; Lo K; Schlenker-Herceg R; Barnathan ES
    Am J Clin Dermatol; 2008; 9(3):155-61. PubMed ID: 18429644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.
    Baughman RP; Lower EE; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):76-89. PubMed ID: 19382527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy.
    Baughman RP; Iannuzzi M
    BioDrugs; 2003; 17(6):425-31. PubMed ID: 14614765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.
    Yee AM; Pochapin MB
    Ann Intern Med; 2001 Jul; 135(1):27-31. PubMed ID: 11434729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
    Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
    Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory sarcoidosis responding to infliximab.
    Roberts SD; Wilkes DS; Burgett RA; Knox KS
    Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory highly disfiguring lupus pernio: a dramatic and prolonged response to infliximab.
    Blanco R; González-Gay MA; González-López MA; Fernández-Llaca H; González-Vela MC
    Int J Dermatol; 2015 Aug; 54(8):e321-2. PubMed ID: 26147319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.